Suffering an Unfair Job Loss is Tough, our california employment attorneys can help.

Yasmin/Yaz Birth Control Pills: FDA Advisory Panel Advises Including Blood Clot Warning on Their Labels

December 31, 1969

A US Food and Drug Administration advisory panel is recommending that the labeling on Yasmin and Yaz birth control pills be revised to include a warning that taking them may increase the risk of potentially fatal blood clots in the lungs and legs. Granted, while two to four out of every 10,000 women have been known to develop blood clots while taking birth control pills, independent studies have shown that Yaz and Yasmin, in particular, can increase the risk of blood clots two to three times higher risk of blood clots.

The FDA advisory panel met earlier this month. In a 21-5 vote, they determined that the current labeling for Yaz and Yasmin, which only notes that different studies have arrived at conflicting outcomes about whether the blood clot risk is higher, are inadequate. The panel wants more conclusive research conducted.

"A pharmaceutical company's failure to warn of possible health risks from taking any medication can be grounds for a California products liability lawsuit," said Howard Law, PC partner and Anaheim dangerous drug lawyer Vincent Howard. "Do not hesitate to contact our Orange County, California law firm to request your free case evaluation.

The advisory panel met seven months after the FDA announced it would begin looking into this matter. After commissioning a study that found that taking drospirenone-laden birth control pills, such as Yasmin or Yaz, can up the risk of blood clots, the federal agency put out a safety communication in September expressing its lingering concerns.
The panel is now calling for more conclusive research.

Initially marketed as a birth control pill that not just prevents pregnancy but also clears up skin problems and relieves premenstrual syndrome, in the last decade, tens of millions of women turned to Yaz. A few years back, however, Bayer was forced to pull ads claiming this pill treats PMS, which it doesn't.

According to, one woman, who started taking Yaz in 2007 to help her acne and bloating, is now blind. 24-year-old Carissa Ubersox believes this is because she took this pill. Three months after she started taking Yaz, she developed blood clots in her legs that ended up in her lungs. She also suffered a massive double pulmonary embolism and ended up in a coma for nearly two weeks.

Ubersox is now suing Bayer for products liability. She is one of thousands that have filed dangerous drug complaints against Bayer, which makes the drug. Bayer, however continues to deny wrongdoing.

"Drug manufacturers must be held accountable for medications that are less safe than what they are touted as--especially if serious injuries result," says Orange County, California products liability attorney Vincent Howard.

Yasmin and Yasmin have also been linked to gallbladder and circulatory illnesses. They also may increase blood potassium levels to the point that heart attacks, strokes, liver tumors, and death can result.

FDA to Review Safety Issues Surrounding Leading Birth Control Pill Yaz, ABC News, December 6, 2011

FDA wants blood clot risks added to Yaz labels, CBS, December 9, 2011

More Blog Posts:

California Products Liability: Defective Hip Implant Devices Continue Causing Injuries, California Injury Lawyers, December 30, 2011

California Products Liability?: FDA Warns that Lap-Band Ads are Misleading, California Injury Lawyers, December 14, 2011

Transvaginal Mesh Lawsuits Raise Questions About FDA's Medical Device Review Process, California Injury Lawyers, October 20, 2011

Contact Howard Law, PC and ask for your free case evaluation with Anaheim dangerous drug attorney Vincent Howard.